胃癌切除との併用療法

石川 義信; 副島 清治; 福島 松郎; 町田 清朗; 角田 秀雄; 稲葉 馨; 西川 鼎二; 西田 伝; 永野 叡; 菊池 晃

doi:10.5833/jjgs.9.341

[title in Japanese]

Yoshinobu ISHIKAWA, Seiji SOEJIMA, Matsuro FUKUSHIMA, Seiro MACHIDA, Hideo KAKUTA, Kaoru INABA, Teiji NISHIKAWA, Tsutae NISHIDA, Satoshi NAGANO, Akira KIKUCHI

Author information

JOURNAL FREE ACCESS

1976 Volume 9 Issue 3 Pages 341-347

DOI https://doi.org/10.5833/jjgs.9.341

Details

Published: 1976 Received: - Available on J-STAGE: February 17, 2011 Accepted: - Advance online publication: - Revised: -
Correction information
Date of correction: February 17, 2011 Reason for correction: - Correction: TITLE Details: [in Japanese]

Date of correction: February 17, 2011 Reason for correction: - Correction: DTPUB Details: Wrong : 19760530

Date of correction: February 17, 2011 Reason for correction: - Correction: AFFILIATION Details: Wrong :
1) The First Department of Surgery, Tohoku University School of Medicine

Right :
1) The First Department of Surgery, Tohokn University School of Medicine

Date of correction: February 17, 2011 Reason for correction: - Correction: CITATION Details: Right : 2) Ishikawa, Y. et al.: Observation on cancer cells in the blood of patients with carcinoma after operation and chemotherapy. Tohoku J. exp. Med., 78: 25-31, 1962.
3) Ishikawa, Y. et al.: Studies on the estimation of cancer cells in blood by acridine orange fluorescence microscopc mcthod. Tohoku J. exp. Med., 77: 211-215, 1962.
4) Ishikawa, Y. et al.: Clinical significance of successive estimation of the blood catalase activity in the cancer patient during surgical and anticancer drug therapy. Tohoku J. exp. Med., 84: 81-91, 1964.
5) Fukushima, M. et al.: A study on the sensitivity test of cancer cells to anti-cancer drugs. Tohoku J. exp. Med., 89: 251-264, 1966.
34) Ceppellini, R. et. al.: Directional activation of mixed lymphocyte cultures (a preliminary report). Histocompatibility Testing 1965, 225-228, Munksgaard Copenhagen, 1965.
35) Jondal, M. et al.: Surface markers on human T and ßlymphocytes I. a large population of lymphocytcs forming non immunc rosettes with sheep red blood cells. J. Exp. Med., 136: 207-215, 1972.
38) Hcllström, I. E. et al.: Some recent information “blocking antibodies” as studies in vitro. Transpl. Proc. 3: 1221-1227, 1971.
42) Fukushima, M. et al.: Passive transfer of the resistance to tumor with RNA. Tohoku J. cxp. Med., 112: 155-164, 1974.
43) Canty, T. G. & Wunderlich, M. D.: Quantitative in vitro assay of cytotoxic cellular immunity. J. Nat. Cancer Inst., 45: 761-770, 1970.
45) Fukushima, M. et al.: Immunological response of splcnic subccllular fraction obtained from induced Yoshida sarcoma-resistant animals. Tohoku J. exp. Med., 99: 247-254, 1969.
46) Ishikawa, Y. et al.: Passive transfcr of tumorspecific resistance to methylcholanthrcne-induced sarcomas in rats. Tohoku J. exp. Med., 103: 195-201, 1971.
51) Ishikawa, Y. et al.: Immunological response of adoptive transfer for the growth of Yoshida sarcoma. GANN., 59: 453-460, 1968.
60) Nadler, S. H. et. al.: Immunotherapy of malignant disease. Ann. Surg., 99: 733-739, 1970.

Date of correction: February 17, 2011 Reason for correction: - Correction: PDF FILE Details: -

Date of correction: February 17, 2011 Reason for correction: - Correction: CITATION Details: Wrong : 2) Ishikawa, Y. et al.: Observation on cancer cells in the blood of patients with carcinoma after operation and chemotherapy. Tohoku J. exp. Med., 78: 25-31, 1962.
3) Ishikawa, Y. et al.: Studies on the estimation of cancer cells in blood by acridine orange fluorescence microscopc mcthod. Tohoku J. exp. Med., 77: 211-215, 1962.
4) Ishikawa, Y. et al.: Clinical significance of successive estimation of the blood catalase activity in the cancer patient during surgical and anticancer drug therapy. Tohoku J. exp. Med., 84: 81-91, 1964.
5) Fukushima, M. et al.: A study on the sensitivity test of cancer cells to anti-cancer drugs. Tohoku J. exp. Med., 89: 251-264, 1966.
34) Ceppellini, R. et. al.: Directional activation of mixed lymphocyte cultures (a preliminary report). Histocompatibility Testing 1965, 225-228, Munksgaard Copenhagen, 1965.
35) Jondal, M. et al.: Surface markers on human T and ßlymphocytes I. a large population of lymphocytcs forming non immunc rosettes with sheep red blood cells. J. Exp. Med., 136: 207-215, 1972.
38) Hcllström, I. E. et al.: Some recent information “blocking antibodies” as studies in vitro. Transpl. Proc. 3: 1221-1227, 1971.
42) Fukushima, M. et al.: Passive transfer of the resistance to tumor with RNA. Tohoku J. cxp. Med., 112: 155-164, 1974.
43) Canty, T. G. & Wunderlich, M. D.: Quantitative in vitro assay of cytotoxic cellular immunity. J. Nat. Cancer Inst., 45: 761-770, 1970.
45) Fukushima, M. et al.: Immunological response of splcnic subccllular fraction obtained from induced Yoshida sarcoma-resistant animals. Tohoku J. exp. Med., 99: 247-254, 1969.
46) Ishikawa, Y. et al.: Passive transfcr of tumorspecific resistance to methylcholanthrcne-induced sarcomas in rats. Tohoku J. exp. Med., 103: 195-201, 1971.
51) Ishikawa, Y. et al.: Immunological response of adoptive transfer for the growth of Yoshida sarcoma. GANN., 59: 453-460, 1968.
60) Nadler, S. H. et. al.: Immunotherapy of malignant disease. Ann. Surg., 99: 733-739, 1970.

Right : 2) Ishikawa, Y. et al.: Observation on cancer cells in the blood of patients with carcinoma after operation and chemotherapy. Tohoku J. exp. Med., 78: 25-31, 1962.
3) Ishikawa, Y. et al.: Studies on the estimation of cancer cells in blood by acridine orange fluorescence microscopc mcthod. Tohoku J. exp. Med., 77: 211-215, 1962.
4) Ishikawa, Y. et al.: Clinical significance of successive estimation of the blood catalase activity in the cancer patient during surgical and anticancer drug therapy. Tohoku J. exp. Med., 84: 81-91, 1964.
5) Fukushima, M. et al.: A study on the sensitivity test of cancer cells to anti-cancer drugs. Tohoku J. exp. Med., 89: 251-264, 1966.
34) Ceppellini, R. et. al.: Directional activation of mixed lymphocyte cultures (a preliminary report). Histocompatibility Testing 1965, 225-228, Munksgaard Copenhagen, 1965.
35) Jondal, M. et al.: Surface markers on human T and B lymphocytes I. a large population of lymphocytcs forming non immunc rosettes with sheep red blood cells. J. Exp. Med., 136: 207-215, 1972.
38) Hcllström, I. E. et al.: Some recent information “blocking antibodies” as studies in vitro. Transpl. Proc. 3: 1221-1227, 1971.
42) Fukushima, M. et al.: Passive transfer of the resistance to tumor with RNA. Tohoku J. cxp. Med., 112: 155-164, 1974.
43) Canty, T. G. & Wunderlich, M. D.: Quantitative in vitro assay of cytotoxic cellular immunity. J. Nat. Cancer Inst., 45: 761-770, 1970.
45) Fukushima, M. et al.: Immunological response of splcnic subccllular fraction obtained from induced Yoshida sarcoma-resistant animals. Tohoku J. exp. Med., 99: 247-254, 1969.
46) Ishikawa, Y. et al.: Passive transfcr of tumorspecific resistance to methylcholanthrcne-induced sarcomas in rats. Tohoku J. exp. Med., 103: 195-201, 1971.
51) Ishikawa, Y. et al.: Immunological response of adoptive transfer for the growth of Yoshida sarcoma. GANN., 59: 453-460, 1968.
60) Nadler, S. H. et. al.: Immunotherapy of malignant disease. Ann. Surg., 99: 733-739, 1970.

Corresponding author

Correction information

Register with J-STAGE for free!